News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Investors are focusing on next week's U.S. inflation readings and earnings as Middle East tensions and rising oil push inflation expectations higher, clouding rate-cut bets.
  • Israeli airstrikes in Lebanon killed at least 11 people, intensifying the regional conflict and raising geopolitical risk.
  • A powerful explosive was found near the Serbia-Hungary section of the Turkstream gas pipeline, prompting security meetings and energy-security concerns before Hungary's election.
  • Barclays says surging AI workloads are hiking high-bandwidth memory prices, creating a pricing tailwind for Samsung and SK Hynix if they can scale.
  • AI infrastructure demand is creating tactical long setups across Broadcom, Applied Optoelectronics, and related semiconductor and optics suppliers.
  • Cash-rich companies like Crocs, Zillow and UnitedHealth are drawing buyback-driven long pitches as free-cash-flow and balance-sheet strength improve risk/reward.

Latest Articles

Pagaya CFO Sells $147K in Class A Shares After RSU Vesting

Pagaya CFO Sells $147K in Class A Shares After RSU Vesting

Pagaya Technologies Ltd. Chief Financial Officer Evangelos Perros sold 13,004 Class A Ordinary Shares on April 1, 2026, at $11.34 per share for about $147,465. The transaction followed the conversion of 22,766 restricted stock units. Pagaya meanwhile closed two large auto-related securitizations and faces updated analyst views after mixed quarterly…

Ultragenyx CFO Sells $98,202 in Stock as Gene Therapy Filing Advances

Ultragenyx CFO Sells $98,202 in Stock as Gene Therapy Filing Advances

Ultragenyx Pharmaceutical Inc. Chief Financial Officer Howard Horn sold 4,683 shares on April 1, 2026, for $20.97 apiece, totaling $98,202. The transaction, executed under a Rule 10b5-1 trading plan, left Horn with 80,351 shares. Meanwhile, the FDA accepted a resubmitted Biologics License Application for UX111 with a Prescription Drug User Fee Act …

Cardlytics CLO Disposes $39,893 of Stock While Exercising RSUs

Cardlytics CLO Disposes $39,893 of Stock While Exercising RSUs

Cardlytics Chief Legal & Privacy Officer Lynton Nicholas Hollmeyer reported a sale of 40,296 shares of company stock on April 1, 2026, at a weighted average price of $0.99 for proceeds of $39,893, while on the same day exercising restricted stock units that resulted in the acquisition of 85,590 shares. The company recently posted mixed fourth-quart…

Rush Street Interactive COO Disposes $441,444 in Shares

Rush Street Interactive COO Disposes $441,444 in Shares

Rush Street Interactive Chief Operating Officer Mattias Stetz sold 20,000 Class A shares on April 1, 2026, generating proceeds of $441,444 at a weighted average price of $22.0722. The trade, carried out under a pre-arranged 10b5-1 plan, occurred as RSI traded close to a 52-week high of $22.80 following a nearly 99% gain over the past year. Stetz co…

Snowflake Engineering SVP Disposes $592K in Shares Amid Stock Weakness; Leadership Shift Draws Analyst Attention

Snowflake Engineering SVP Disposes $592K in Shares Amid Stock Weakness; Leadership Shift Draws Analyst Attention

Snowflake Inc. SVP of Engineering Vivek Raghunathan executed a sale of 3,876 shares on April 1, 2026, generating $592,252 in proceeds under a pre-arranged 10b5-1 plan. The transaction was disclosed in a Form 4 filing. The company also named Jonathan Beaulier as Chief Revenue Officer following Mike Gannon's departure, a move noted by several analyst…

WEX COO Reduces Stake, Sells $532K in Company Stock

WEX COO Reduces Stake, Sells $532K in Company Stock

WEX Inc. COO Joel Alan Dearborn Jr. sold 3,503 shares on April 1, 2026, through an automatic Rule 10b5-1 plan for $532,488. The shares traded between $147.93 and $152.71. WEX reported stronger-than-expected fourth-quarter 2025 results and continues active buybacks, yet shares declined amid broader market concerns and analysts maintained neutral-to-…